After delivery, the umbilical cord is detached from the new-born baby. The blood left in this cord has hematopoietic (blood) stem cells, which can be used for treating many diseases. The collection process is very easy and painless, with no harm to the child or the mother. These cells are very rare; they are also found in bone marrow. The hematopoietic stem cells (HSCs) have the ability to make red cells, white cells and platelets in the blood. For the past many years, these cells from bone marrow are used for curing blood diseases.
With Cryobanks India, more and more expectant parents are now looking forward to saving their baby’s cord blood. Latest technologies are used for storing the blood cells safely for future use. In comparison to bone marrow cells, there are many benefits of cord blood banking. They are easy to collect and store, and are readily available for treatments. Even the problems of Graft versus Host Disease are less with cord blood cells. People can use them against cancerous blood disorders or other genetic diseases. In stem cell therapy, the patient is injected with these blood cells. They start to regenerate new cells while replacing the withered cells in the body. The recovery process might take some time, but the results are long-lasting.
However, there are certain limitations too. With cord blood cells, treatments on non-blood-related diseases are not done till date. Many researchers are looking out for solutions by doing different experiments. Another limitation is that a single cord blood does not have as many hematopoietic cells as found in bone marrow. Thus, treating an adult patient with cord blood becomes difficult as they require more HSCs. Therefore, different researches are being done for solving this issue. In many laboratories, focus is given in increasing the total count of HSCs by multiplying the cells. Researchers believe that in the future, the use of umbilical cord blood stem cells is going to increase as its potential is very high.